About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Long-term synaptic plasticity and memory requires neuronal activity-induced gene expression regulated by the transcription factor cAMP-response element binding protein (CREB). CREB-dependent gene expression requires transcriptional coactivators, such as CREB binding protein (CBP/P300) and CREB-regulated transcription coactivator-1 (CRTC1). However, the specific gene programs regulated by CRTC1 during induction of neuronal activity remain unknown. Using chromatin immunoprecipitation sequencing (ChIP-seq), we analyzed the genome-wide occupancy profiles of CRTC1 in cultured neurons in both basal and stimulated conditions after treatment with forskolin and potassium chloride (FSK/KCl), which induces CRTC1 dephosphorylation, nuclear translocation and binding to promoter regions of target genes. We detected strong induction of CRTC1 occupancy in a subset of CREB target genes upon FSK/KCl treatment, including proximal promoter regions and distal regions comprising well-characterized neuronal activity-regulated enhancers. Interestingly, we identified activity-dependent binding of CRTC1 at genes mediating neuronal excitability and synaptic plasticity, including neurotransmitter receptors, synaptic proteins and transcriptional regulators. These results suggest that CRTC1 regulates gene programs supporting local synaptic plasticity and global neuronal excitability.
Host: Cell Signaling and apoptosis (VHIR)
Format: Free access and free face-to-face. Online: register
https://gencat.zoom.us/j/99144261702